Density plot of LDL-C levels in Genotype-Positive Familial Hypercholesterolemia(FH) and regression model of cardiovascular phenotypes. Plot A shows density of FH and Noncarrier, plot B shows regression model of cardiovascular phenotypes.
Genotype-positive #FamilialHypercholesterolemia in US adults was linked to higher atherosclerotic cardiovascular disease rates and lower achievement of guideline-recommended LDL-C targets. ja.ma/4cgSNXO
Explore this #CME program on pediatric HoFH with expert insights on screening, diagnosis, and treatment to help prevent early cardiovascular disease.
▶️ Watch now: bit.ly/47Bz4za
#Cardiology #FamilialHypercholesterolemia #MedicalEducation
Density plot of maximum LDL-C values and regression model of cardiovascular phenotypes. Plot A compares FH and Noncarrier LDL-C, while plot B shows odds ratios for phenotypes like ASCVD, CAD, PAD, TIA, Hypertension, Obesity, Diabetes and Smoking.
Genotype-positive #FamilialHypercholesterolemia in US adults was linked to higher atherosclerotic cardiovascular disease rates and lower achievement of guideline-recommended LDL-C targets.
ja.ma/4uj6lsM
Density plot comparing max LDL-C values in FH vs. noncarriers. Regression model shows cardiovascular phenotypes like ASCVD, CAD, PAD, TIA, Hypertension, Obesity, Diabetes, Smoking; OR values range from 1 to 4. FH peaks around 200, noncarrier around 100.
Genotype-positive #FamilialHypercholesterolemia in US adults was linked to higher atherosclerotic cardiovascular disease rates and lower achievement of guideline-recommended LDL-C targets.
ja.ma/4cu0har
Density plot of maximum recorded LDL-C values in Genotype-Positive Familial Hypercholesterolemia (FH) & regression model of cardiovascular phenotypes. Density shows FH & Noncarrier LDL-C levels. Regression plots ASCVD, CAD, PAD, TIA, & other phenotypes.
Genotype-positive #FamilialHypercholesterolemia in US adults was linked to higher atherosclerotic cardiovascular disease rates and lower achievement of guideline-recommended LDL-C targets.
ja.ma/3OFQODa
#FamilialHypercholesterolemia raises mortality risk in #PrematureCoronaryArteryDisease patients, despite similar #MACCE rates. Large-scale cohort study highlights critical need for targeted intervention. jthc.tums.ac.ir/index.php/jt...
ACC’s #FamilialHypercholesterolemia online course will keep you up to date on the latest tools & techniques to recognize HoFH & HeFH – a life-changing diagnosis that provides access to early treatment options. More ➡️ https://bit.ly/4mdjDlm
#ACCEd #CholesterolEducationMonth #CardioSky #MedSky
#cardiogenetics #familialhypercholesterolemia- www.linkedin.com/posts/lifesc... -follow @nmgenomix.bsky.social for more news related to cardiogenetics
📢 Newly Published!
🩺 LDL Cholesterol Burden in Elderly Patients with Familial Hypercholesterolemia: Insights from real-world data.
🔗 Read more: ow.ly/47hb50VrFIb
#Cardiology #Cholesterol #FamilialHypercholesterolemia #HeartHealth #CardioSky #MedSky
Big thanks to @pollyhansen.bsky.social for the opportunity to spread the word about #familialhypercholesterolemia and elevated #lpa (and to mention my new memoir, The Full Catastrophe, which illustrates the impact of early loss due to undiagnosed, treatable genetic disorders on those who survive).
When @splitlipthemag.bsky.social says you’re in the fam, they mean it!
Thanks to @wnyt.bsky.social & Split Lip for allowing me to spread the word about #familialhypercholesterolemia and my memoir, The Full Catastrophe. Grief & joy walk hand in hand & spur us to make a difference wherever we can.
Loved chatting with @tamarastarr.bsky.social at @wnyt.bsky.social about #familialhypercholesterolemia, the work of @familyheartfdn.bsky.social, and my new memoir! Learn more at www.caseymulliganwalsh.com
NEW 2024 Polish #Recommendations for the #Management of #FamilialHypercholesterolemia in #Children and #Adolescents have been just released in #AMS! They update the ones published 10 years ago, based on the most critical recent data in the field 💪
www.archivesofmedicalscience.com/2024-Polish-...
Racial disparities lead to the disproportionately high burden of ASCVD in Black patients with #FamilialHypercholesterolemia. #knowFH
We can advocate for our Black patients via 1° prevention- HTN management & smoking cessation. #CVprev #healthequity #AHA20 @AHAMeetings
Racial disparities lead to the disproportionately high burden of ASCVD in Black patients with #FamilialHypercholesterolemia. #knowFH
We can advocate for our Black patients via 1° prevention- HTN management & smoking cessation. #CVprev #healthequity #AHA20 @AHAMeetings
